If you want to know some tips and tricks about how to approach tricky LAAC cases, don't miss the dedicated session at the EuroPCR Congress! PCRonline 🫀

#ResearchLetter At one-year, no difference in outcomes was observed between two of the most common left atrial appendage closure devices (Amulet vs Watchman) Roberto Galea Marco Valgimigli Cardiovascular Research Cluster (CVRC) ahajournals.org/doi/10.1161/CI…

Going home after the very 1st annual @EuropeanLAACC gathering in Barcelona🇪🇸, meeting new friends while promoting a collective European effort towards improving safety and facilitating future quality research in #LAAO !
Bonus quiz: Guess my birdseye view 😎
#ELAACC2024

#RCM #cardiovascular Article Share

💐'Antithrombotic Therapy after Percutaneous Left Atrial Appendage Closure: Evidence, Challenges and Future Directions' by Roberto Galea, Lorenz Räber, MD PhD

#LAAC #antithrombotic #bleeding #anticoagulation #AF

💌Full Text:
imrpress.com/journal/RCM/24…

#TCT2023 One-year outcomes after Amulet or Watchman/FLX device for percutaneous left atrial appendage closure

Alessandro Sticchi interviews 🎤 Roberto Galea about the 1-year results of the SWISS-APERO randomized clinical trial 📊

pcronline.com/News/Whats-new…

#cardiotwitter

Catch up on #TCT2023 news you may have missed:

SWISS-APERO at 1 year: LAA closure outcomes similar for Amulet, Watchman devices

Marco Valgimigli TCT Conference

Link ⬇️

healio.com/news/cardiac-v…

So glad to finally share !

Computed Tomography Scan Evidence for Left Atrial Appendage Short‐Term Remodeling Following Percutaneous Occlusion: Impact of Device Oversizing | Journal of the American Heart Association ahajournals.org/doi/10.1161/JA…

Drs. Roberto Galea, Lorenz Räber, MD PhD et al find significant improvement in procedural success with preprocedural CT to plan LAAC in a post-hoc analysis of the SWISS-APERO Trial. bit.ly/3JkA2nj

#JACCINT #cvLAAoccluder #CardioTwitter Christoph Gräni Marco Valgimigli

In a RCT of Apixaban vs Warfarin for dialysis patients with AF published in Circulation bleeding events were 10-FOLD more frequent than ischemic events

May be OAC is not the answer here? ahajournals.org/doi/10.1161/CI…

The use of a steerable sheath for both the transseptal puncture and device deployment allowed us to complete a percutaneous LAAC procedure with superior vascular access. Cardiovascular Research Cluster (CVRC) Lorenz Räber, MD PhD
#LAAC EuroIntervention eurointervention.pcronline.com/article/percut…

Transeptal puncture: fellow, and senior EP.

twitter.com/buitengebieden…

Small Peri-Device Leak (≤ 5mm) after LAAO are Associated with ⬆️ Thromboembolic Events at 1-Year. #ACC22 doi.org/10.1016/j.jace…

Tackling stroke requires effective🫀🧠 🤝

Our paper published in the inaugural issue of JACC Advances discuses the key role of the ‘Heart Brain Team’ in preventing & caring for ischemic stroke

jacc.org/doi/full/10.10…

We are honoured that our WATCH-DUAL study was selected as paper of the week in #europace European Society of Cardiology Journals Lorenz Räber, MD PhD Nicolas Amabile Marco Valgimigli

Love this.

Less DRT, lower device permeability, better LAA neck coverage: welcome to the new #Watchman FLX! Lorenz Räber, MD PhD Nicolas Amabile Marco Valgimigli Christoph Gräni #SWindecker academic.oup.com/europace/advan…

ACS on admission independently predicted the risk of #bleeding in 16,821 pts undergoing PCI. Clinical presentation affects, therefore, both #ischemic and bleeding risks.

Marco Valgimigli Davide Capodanno EuroIntervention PCRonline 🫀 SIC Società Italiana di Cardiologia CardioTalk CardioInfo Italian Cardiologists Of Tomorrow

LAAC procedure appears feasible and safe even in presence of LAA thrombus: the international, multicentre TRAPEUR registry EuroIntervention eurointervention.pcronline.com/article/left-a… Lorenz Räber, MD PhD Nicolas Amabile EuroIntervention